Resonance Specialties Share Price
Sector: Chemical Manufacturing
111.66 +5.49 (5.17%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
109.01
Today’s High
120.00
52 Week Low
65.00
52 Week High
117.50
Key Metrics
- Market Cap (In Cr) 128.9
- Beta 1.72
- Div. Yield (%) 0
- P/B 2.24
- TTM P/E 26.9
- Sector P/E 17.01
- Open Price 115
- Prev Close 106.17
Resonance Specialties Analysis
Price Analysis
-
1 Week37.23%
-
3 Months42.55%
-
6 Month7.94%
-
YTD14.99%
-
1 Year6.65%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Resonance Specialties Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 55.3
- Selling/ General/ Admin Expenses Total
- 9.12
- Depreciation/ Amortization
- 1.46
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 41.91
- Operating Income
- 13.39
- Net Income Before Taxes
- 3.96
- Net Income
- 2.97
- Diluted Normalized EPS
- 2.58
- Period
- 2024
- Total Assets
- 73.77
- Total Liabilities
- 16.28
- Total Equity
- 57.5
- Tangible Book Valueper Share Common Eq
- 48.88
- Period
- 2024
- Cashfrom Operating Activities
- 4.16
- Cashfrom Investing Activities
- -6.63
- Cashfrom Financing Activities
- 0.33
- Net Changein Cash
- -2.13
- Period
- 2023
- Total Revenue
- 58.81
- Selling/ General/ Admin Expenses Total
- 9.65
- Depreciation/ Amortization
- 1.48
- Other Operating Expenses Total
- 0.04
- Total Operating Expense
- 33.98
- Operating Income
- 24.84
- Net Income Before Taxes
- 6.85
- Net Income
- 5
- Diluted Normalized EPS
- 4.33
- Period
- 2023
- Total Assets
- 65.79
- Total Liabilities
- 10.1
- Total Equity
- 55.69
- Tangible Book Valueper Share Common Eq
- 47.71
- Period
- 2023
- Cashfrom Operating Activities
- -8.37
- Cashfrom Investing Activities
- 3.2
- Cashfrom Financing Activities
- 0.93
- Net Changein Cash
- -4.24
- Period
- 2022
- Total Revenue
- 74.22
- Selling/ General/ Admin Expenses Total
- 8.69
- Depreciation/ Amortization
- 1.75
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 41.14
- Operating Income
- 33.07
- Net Income Before Taxes
- 16.29
- Net Income
- 12.36
- Diluted Normalized EPS
- 10.7
- Period
- 2022
- Total Assets
- 56.77
- Total Liabilities
- 4.97
- Total Equity
- 51.8
- Tangible Book Valueper Share Common Eq
- 44.73
- Period
- 2022
- Cashfrom Operating Activities
- 13.33
- Cashfrom Investing Activities
- -8.8
- Cashfrom Financing Activities
- -1.86
- Net Changein Cash
- 2.66
- Period
- 2021
- Total Revenue
- 70.29
- Selling/ General/ Admin Expenses Total
- 3.8
- Depreciation/ Amortization
- 0.98
- Other Operating Expenses Total
- 26.25
- Total Operating Expense
- 57.02
- Operating Income
- 13.27
- Net Income Before Taxes
- 14.56
- Net Income
- 10.52
- Diluted Normalized EPS
- 9.12
- Period
- 2021
- Total Assets
- 54.63
- Total Liabilities
- 13.96
- Total Equity
- 40.67
- Tangible Book Valueper Share Common Eq
- 35.01
- Period
- 2021
- Cashfrom Operating Activities
- 4.28
- Cashfrom Investing Activities
- -1.18
- Cashfrom Financing Activities
- 0.31
- Net Changein Cash
- 3.42
- Period
- 2020
- Total Revenue
- 56.2
- Selling/ General/ Admin Expenses Total
- 3.9
- Depreciation/ Amortization
- 0.92
- Other Operating Expenses Total
- 23.62
- Total Operating Expense
- 50.81
- Operating Income
- 5.39
- Net Income Before Taxes
- 6.92
- Net Income
- 5.51
- Diluted Normalized EPS
- 5.78
- Period
- 2020
- Total Assets
- 41.12
- Total Liabilities
- 10.59
- Total Equity
- 30.53
- Tangible Book Valueper Share Common Eq
- 26.2
- Period
- 2020
- Cashfrom Operating Activities
- 1.42
- Cashfrom Investing Activities
- -1.72
- Cashfrom Financing Activities
- 1.15
- Net Changein Cash
- 0.86
- Period
- 2019
- Total Revenue
- 41.63
- Selling/ General/ Admin Expenses Total
- 2.97
- Depreciation/ Amortization
- 0.91
- Other Operating Expenses Total
- 15.78
- Total Operating Expense
- 37.73
- Operating Income
- 3.9
- Net Income Before Taxes
- 4.76
- Net Income
- 3.2
- Diluted Normalized EPS
- 2.83
- Period
- 2019
- Total Assets
- 38.17
- Total Liabilities
- 11.7
- Total Equity
- 26.47
- Tangible Book Valueper Share Common Eq
- 22.64
- Period
- 2019
- Cashfrom Operating Activities
- 5.27
- Cashfrom Investing Activities
- -0.5
- Cashfrom Financing Activities
- -3.65
- Net Changein Cash
- 1.11
- Period
- 2024-12-31
- Total Revenue
- 18.24
- Selling/ General/ Admin Expenses Total
- 1.18
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 3.73
- Total Operating Expense
- 13.58
- Operating Income
- 4.66
- Net Income Before Taxes
- 1.63
- Net Income
- 1.12
- Diluted Normalized EPS
- 0.96
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 18.06
- Selling/ General/ Admin Expenses Total
- 1.21
- Depreciation/ Amortization
- 0.49
- Other Operating Expenses Total
- 3.63
- Total Operating Expense
- 11.54
- Operating Income
- 6.53
- Net Income Before Taxes
- 2.21
- Net Income
- 1.81
- Diluted Normalized EPS
- 1.47
- Period
- 2024-09-30
- Total Assets
- 73.66
- Total Liabilities
- 13.78
- Total Equity
- 59.87
- Tangible Book Valueper Share Common Eq
- 50.99
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 3.64
- Cashfrom Investing Activities
- -3.6
- Cashfrom Financing Activities
- -0.53
- Net Changein Cash
- -0.49
- Period
- 2024-06-30
- Total Revenue
- 17.3
- Selling/ General/ Admin Expenses Total
- 1.21
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 2.94
- Total Operating Expense
- 13.24
- Operating Income
- 4.06
- Net Income Before Taxes
- 0.86
- Net Income
- 0.59
- Diluted Normalized EPS
- 1.04
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 16.36
- Selling/ General/ Admin Expenses Total
- 1.29
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 2.02
- Total Operating Expense
- 13.59
- Operating Income
- 2.77
- Net Income Before Taxes
- 0.85
- Net Income
- 0.67
- Diluted Normalized EPS
- 0.59
- Period
- 2024-03-31
- Total Assets
- 73.77
- Total Liabilities
- 16.28
- Total Equity
- 57.5
- Tangible Book Valueper Share Common Eq
- 48.88
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 4.16
- Cashfrom Investing Activities
- -6.63
- Cashfrom Financing Activities
- 0.33
- Net Changein Cash
- -2.13
- Period
- 2023-12-31
- Total Revenue
- 15.34
- Selling/ General/ Admin Expenses Total
- 1.2
- Depreciation/ Amortization
- 0.38
- Other Operating Expenses Total
- 3.32
- Total Operating Expense
- 12.57
- Operating Income
- 2.77
- Net Income Before Taxes
- 1.08
- Net Income
- 0.96
- Diluted Normalized EPS
- 0.83
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Resonance Specialties Technical
Moving Average
SMA
- 5 Day82.33
- 10 Day79.87
- 20 Day79.09
- 50 Day78.91
- 100 Day85.69
- 300 Day94.06
Resonance Specialties Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Basant Agro Tech India
- 13.96
- -0.04
- -0.29
- 24.9
- 11
- 125.8
- Genpharmasec
- 2.24
- -0.03
- -1.32
- 4.32
- 1.89
- 123.48
- Resonance Specialties
- 111.66
- 5.49
- 5.17
- 117.5
- 65
- 128.9
- Daikaffil Chemicals India
- 160.1
- -5.6
- -3.38
- 281
- 83.91
- 100.08
- Alkali Metals
- 108.38
- 18.06
- 20
- 165
- 75.26
- 108.34
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Basant Agro Tech India
- 32.06
- 0.73
- 7.98
- 2.9
- Genpharmasec
- -
- 1.88
- 2.7
- 2.49
- Resonance Specialties
- 41.17
- 2.13
- 16.48
- 11.55
- Daikaffil Chemicals India
- -
- 9.44
- -6.07
- -16.32
- Alkali Metals
- 64.42
- 1.79
- 2.95
- 1.95
Resonance Specialties Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 19-May-25
- Audited Results & Final Dividend
- 24-Jan-25
- Quarterly Results
- 23-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results
- 06-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 08-Aug-23
- Quarterly Results
- 11-May-23
- Audited Results
- 02-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 02-Aug-24
- 08-Jul-24
- AGM
- 08-Aug-23
- 11-Jul-23
- AGM
- 20-Mar-23
- 15-Feb-23
- POM
- 26-Aug-21
- 02-Aug-21
- AGM
- 12-Mar-21
- 08-Feb-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 19-May-25
- 29-Jul-25
- -
- 1
- 11-May-23
- -
- 01-Aug-23
- 1
- 11-May-22
- 05-Aug-22
- 04-Aug-22
- 1
- 03-Jun-21
- 20-Aug-21
- 18-Aug-21
- 1


